Related Experiment Video
Updated: Jan 3, 2026
Molecular Imaging of Human Brain Organoids Using Mass Spectrometry
Published on: September 27, 2024
Molecular Imaging in Pediatric Brain Tumors
Agostino Chiaravalloti1,2, Luca Filippi3, Maria Ricci4
1Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
Abstract:
In the last decade, several radiopharmaceuticals have been developed and investigated for imaging in vivo of pediatric brain tumors with the aim of exploring peculiar metabolic processes as glucose consumption, amino-acid metabolism, and protein synthesis with nuclear medicine techniques. Although the clinical shreds of evidence are limited, preliminary results are encouraging. In this review, we performed web-based and desktop research summarizing the most relevant findings of the literature published to date on this topic. Particular attention was given to the wide spectrum of nuclear medicine advances and trends in pediatric neurooncology and neurosurgery. Furthermore, the role of somatostatin receptor imaging through single-photon emission computed tomography (SPECT) and positron emission tomography (PET) probes, with reference to their potential therapeutic implications, was examined in the peculiar context. Preliminary results show that functional imaging in pediatric brain tumors might lead to significant improvements in terms of diagnostic accuracy and it could be of help in the management of the disease.
Insights
Nuclear medicine techniques like PET and SPECT offer promising functional imaging for pediatric brain tumors. These methods aid in diagnosing and managing brain cancers by assessing metabolic processes.
Area of Science:
- Nuclear Medicine
- Pediatric Oncology
- Neuroimaging
Background:
- Radiopharmaceuticals are increasingly used for in vivo imaging of pediatric brain tumors.
- Focus is on metabolic processes like glucose consumption, amino-acid metabolism, and protein synthesis.
Purpose of the Study:
- To review advances in nuclear medicine for pediatric brain tumors.
- To explore the role of somatostatin receptor imaging (SPECT/PET) and its therapeutic potential.
Main Methods:
- Web-based and desktop literature research.
- Summarizing findings on nuclear medicine in pediatric neurooncology and neurosurgery.
- Examining somatostatin receptor imaging (SPECT/PET).
Main Results:
- Preliminary results for functional imaging in pediatric brain tumors are encouraging.
- Nuclear medicine techniques show potential for improved diagnostic accuracy.
- Functional imaging may assist in disease management.
Conclusions:
- Functional imaging using radiopharmaceuticals shows promise for pediatric brain tumors.
- SPECT and PET imaging, including somatostatin receptor probes, are valuable tools.
- These techniques could significantly improve diagnosis and management of pediatric brain tumors.
